Subcutaneous Low Dose Alemtuzumab: Role As a Salvage Therapy in Immune -Mediated Marrow Failure Conditions
Year: 2016
Type: article
Study design: Observational Study
Source: Blood
Institutions: Cleveland Clinic, University of Naples Federico II
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2612397484
